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Summary 
Interferon (IFN) y  induces replacements of the proteasomal subunits X  and Y by LMP7 and 
LMP2, respectively, resulting in an alteration of the proteolytic specificity.  We found a third 
pair ofproteasome subunits expressed  reciprocally in response to IFN-y. Molecular cloning of 
a cDNA encoding one subunit designated as Z, downregulated by IFN-% showed that it is a 
novel proteasomal subunit with high homology to MECL1, which is markedly induced by 
IFN-% Thus, IFN-~/induces subunit replacements of not only X  and Y by LMP7 and LMP2, 
respectively, but also of Z by MECL1, producing proteasomes responsible for immunological 
processing of endogenous antigens. When processed from their precursors, three pairs of the 10 
homologous, but distinct, [3-type subunits of eukaryotic proteasomes,  that is, X/LMP7, Y/LMP2, 
and Z/MECL1, have an NH2-terminal threonine residue, assumed to be part  of a  catalytic 
center.  These findings suggest that the altered molecular organization of the proteasome in- 
duced by IFN-y may be responsible for acquisition of its functional change. 
p roteasomes are present in cells as both 20S and 26S iso- 
forms with molecular masses of ~750  and 2,000  kD, 
respectively (for reviews see references 1-3).  The eukary- 
otic 20S  proteasome is a  cylindrical particle  consisting of 
four rings, each of which is organized from seven homolo- 
gous, but not identical, 0~ and [3 subunits, assembled in the 
order 0t[3[3ot (4). All proteasomal genes examined so far en- 
code previously unidentified proteins, which show consid- 
erable  intersubunit homology in the same species and high 
evolutionary conservation in various eukaryotes  (5). The 
26S proteasome appears to be a dumbbell-shaped particle with 
two large terminal subsets attached in opposite orientations 
to a smaller, four-layered central 20S proteasome (6, 7). 
The  20S  proteasome  is  a  multicatalytic proteinase  re- 
sponsible for endoproteolytic cleavage  ofpeptide bonds on 
the carboxyl side  of acidic, basic,  and hydrophobic amino 
acid residues  of proteins (8). The manifestation of multiple 
catalytic activities at independent active sites within a single 
enzyme complex appears  advantageous for the  rapid  and 
complete breakdown of various types of cellular proteins. 
The multicatalytic functions of proteasomes may also gen- 
erate suitable types ofpeptides from target proteins, as pro- 
teasomes have recently been  implicated in processing for 
MHC  class I-restricted  antigen presentation  (see below). 
Although the 20S proteasome is able to hydrolyze various 
small  peptides,  it  is  not  responsible  for  endoproteolytic 
breakdown of any kind of large protein substrates.  In con- 
trast,  the 26S  proteasome is a eukaryotic ATP-dependent 
protease degrading a variety of cellular proteins that have a 
specific degradation signal(s) such as a multiubiquitin chain 
(9, 10). Covalent attachment of ubiquitin to target proteins 
acts  as a degradation signal  for their selective breakdown 
(11). The ubiquitin-proteasomal pathway appears to be in- 
volved in the selective  removal of regulatory proteins with 
a rapid turnover related to cell cycle progression, transcrip- 
tion,  and metabolic regulation  (12,  13). In  addition, the 
26S  proteasome  is  also  responsible  for  ATP-dependent 
degradation of ornithine decarboxylase, which has an ex- 
tremely rapid turnover rate. The degradation does not de- 
pend on ubiquitination but on the association of ornithine 
decarboxylase with its  specific  inhibitor protein antizyme 
(14). Intriguingly, the ubiquitin-proteasome system catalyzes 
not only exhaustive proteolysis of these naturally occurring 
short-lived proteins and abnormal/malfolded proteins gen- 
erated in cells (15). It also activates the transcriptional factor 
NF-KB through conversion of the p105  precursor to p50 
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teasome is a most important enzyme responsible for the en- 
ergy-dependent nonlysosomal proteolytic pathway. 
The ubiquitin-proteasome  system has  also  been  shown 
to be involved in  the  processing of endogenous  antigens, 
which are presented with the class I cell surface MHC, be- 
cause  marked  suppression  of the  generation  of antigenic 
peptides  was  observed  both  in  cells  with  a  temperature- 
sensitive ubiquitin-activating enzyme (El) at the restrictive 
temperature  (17)  and  in  cells  where  proteasome function 
was suppressed with peptide-aldehyde inhibitors (15). Thus 
the proteasome is implicated to be an enzyme responsible 
for the processing ofintracellular antigens to generate pep- 
tides,  which  are  then  transported  into  the  endoplasmic 
reticulum through  the  transporter associated with  antigen 
processing (TAP) 1 peptide transport system (for review see 
reference 18). 
Studies  on the effect of IFN-y are of particular interest 
for revealing the  exact role  of the proteasome in  the  im- 
mune system, because IFN-y is a major immunomodula- 
tory cytokine. Actually, IFN-',/alters the proteolytic speci- 
ficity of proteasomes, modulating their ability to generate 
peptides for antigen presentation  (19-21).  Two polymor- 
phic MHC-encoded proteasomal genes, LMP2 and LMP7, 
were found  to  be  localized  in  the  class  II MHC  region 
closely linked to two homologous genes, TAP1 and TAP2, 
which are responsible for transport ofpeptides from the cy- 
tosol  into  the  endoplasmic  reticulum  (22).  The  involve- 
ment of  LMP2 and LMP7 in the processing pathway has been 
demonstrated directly by gene disruption in mice (23,  24). 
Recently,  we  found  that  IFN-y  induced  not  only 
marked  synthesis  of the  MHC-encoded  proteasome sub- 
units  LMP2  and  LMP7,  but  also  almost complete loss  of 
two unidentified proteasome subunits  designated as X  and 
Y  in cells  (21).  Similar results have also been presented by 
other investigators  (25,  26).  Molecular cloning of cDNAs 
encoding X  and Y  showed that X  (also named MB1  or e) 
and  Y  (equivalent  to  8)  are  novel  proteasomal  subunits 
with  high  homology  to  LMP7  and  LMP2,  respectively 
(27-29).  This adaptation is proposed to be due to IFN-y- 
dependent subunit replacements of X  and Y  by the struc- 
turally similar subunits LMP7 and LMP2,  respectively, be- 
cause  these  pairs  of subunits  with  extremely high  amino 
acid  similarity have been shown  to  be  expressed recipro- 
cally in response to  IFN-y (30).  However,  the necessities 
of LMP2 and LMP7 in the antigen processing pathway are 
controversial, because their  deletions  were found  to  have 
no significant effect on the presentation of endogenous an- 
tigens (31-34). 
In this study,  we examined the role of IFN-y in more 
detail and found two new subunits regulated reciprocally in 
response to IFN-y. Molecular cloning of a cDNA-encod- 
ing subunit Z, downregulated by IFN-% showed that this 
subunit has high homology to MECL1, which is markedly 
1Abbreviations used in this  paper: 2D-PAGE, two-dimensional  PAGE; TAP, 
transporter associated with antigen processing. 
upregulated in response to IFN-y. This is the first  indica- 
tion that IFN-y induces subunit replacements of not only 
X  and Y  by LMP7 and LMP2,  respectively, but also  of Z 
by MECL1,  producing proteasomes that would  modulate 
processing of endogenous  antigens.  These  findings  are  of 
considerable importance in  clarifying the  role  of the pro- 
teasome in the antigen-processing pathway. 
Materials and Methods 
cDNA Cloning.  A  cDNA library  of human  hepatoblastoma 
HepG2 cells was constructed  in a ZAPII phage expression vector 
(Stratagene Inc., LaJolla, CA). For isolation ofcDNA for subunit 
Z,  "-~5 ￿  105  plaques  were  screened  by hybridization  with  a 
cDNA fragment that had been synthesized by PCR and labeled 
with  [oL-32p]dCTP. After  plaque  hybridization,  the  pBluescript 
plasmid was excised and  directly  sequenced  by a double-strand 
strategy in an automated DNA sequencer  (Pharmacia LKB Bio- 
technology Inc., Piscataway, NJ). 
Chromosomal Mapping.  Direct R-banding fluorescence in situ 
hybridization  (FISH) based on FISH combined with  the  repli- 
cated prometaphase  R-band was applied.  For suppression of re- 
petitive sequences contained in this clone, we used human Cot-1 
DNA  (Bethesda Research  Laboratories,  Gaithersburg,  MD)  as 
described by Lichter et al. (35) with slight modifications (36). La- 
beling, hybridization,  rinsing, and detection were carried out by 
routine procedures.  Provia  100 (ISO100;  Fuji, Tokyo) was used 
for microphotography  (filter  combination,  B-2A;  Nikon,  To- 
kyo).  We isolated four independent  genomic clones of protea- 
some Z  (Z-3, -5, -12, and -13) and used each clone as a probe. 
These  clones  contained  an  insert  of "~  kb  in  the  pWE15 
cosmid vector. The library was purchased from Clontech Labora- 
tories, Inc. (Palo Alto, CA). 
Immunological Analyses.  50-1*g samples of cell  extracts  were 
subjected to SDS-PAGE  and then used for immunoblot analysis 
(21). mAbs MCP168 and MCP421  (37) against Z and Y, respec- 
tively,  and  polyclonal  antipeptide  antibodies  against  subunits 
LMP2, LMP7, X, and MECL1 were used. 
Northern Blot Analysis.  10-b~g samples of total  RNA  were 
separated by electrophoresis  in agarose gel containing  formalde- 
hyde, transferred to a nylon membrane (Hybond-N+; Amersham 
Corp.,  Arlington  Heights,  IL) and hybridized  with 32p-labeled 
probes as described previously (21). For Northern blot analysis of 
proteasomes,  cDNAs for subunits LMP2,  LMP7  (21), X, and Y 
(28) of human proteasomes  and  the  cDNA of [3-actin (Oncor 
Inc., Gaithersburg, MD) were used. Approximately 820-bp cDNAs 
of MECL1  of human  proteasomes  were  synthesized  by  PCR 
based  on  reported  sequences  (38). These  probes  were  labeled 
with  a  commercial  kit  for multiprime  DNA  labeling  (Takara 
Shuzo, Kyoto, Japan). The membranes were washed and autorad- 
iographed  with XAR-5  film  (Eastman Kodak Co.,  Rochester, 
NY) at -70~  using an intensifying screen. 
Computer Analysis.  Computer-assisted homology research was 
carried  out using the databases listed in  LASL-GDB  (GenBank) 
and NBRF-PDB. 
Results 
IFN-T-dependent  Changes  in  Subunit  Composition  of the 
Proteasome.  The effect of IFN-3, on the functions of the 
proteasome is quite controversial (19-21,  25, 39).  To clar- 
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the  proteasome,  we  first  reinvestigated carefully whether 
IFN-y alters its subunit pattern in human  cells. HeLa cells 
were metabolically labeled with [3H]leucine, and their pro- 
teasomes were immunoprecipitated and subjected to  two- 
dimensional  PAGE  (2D-PAGE).  Spots  corresponding  to 
LMP2 and LMP7, induced by IFN-% and subunits X  and 
Y, downregulated by IFN-~/(Fig. 1), were observed, as re- 
ported previously (25-27).  On closer inspection of the flu- 
orogram, we found two other spots of subunits whose ex- 
pressions  are  controlled  reciprocally  by  IFN-y  (Z  and 
MECL1, Fig. 1 A  and B). Similar alterations of unidentified 
subunits were also found in mouse cells (25),  although it is 
unknown  whether  these  subunits  correspond  to  those  of 
HeLa cells. 
To  characterize these two proteins, we immunoprecipi- 
tated proteasomes from extracts of HeLa cells with or with- 
out IFN-y treatment and separated them in larger amounts 
by 2D-PAGE and blotting. The NH2-terminal sequence of 
the protein upregulated by IFN-~/(circled in Fig. 1 D) was 
determined by Edman  degradation directly from the blot. 
The  sequence,  XTIAGLVFQDGVILGADTI<  is identical 
to that ofMECL1, which has been cloned as a unique gene 
within  a  tight  cluster  of five  unrelated  human  genes  on 
chromosome  16q22.1  (38).  The protein downregulated by 
IFN-'y (circled in Fig.  1  C)  has been shown  to  react with 
mAb  MCP168  (37)  and  has  been  named  subunit  Z.  Se- 
quencing of a proteolytic fragment of Z  (ITPLEIEVLEEX- 
VQTMD)  showed that Z  is a novel proteasomal subunit. 
High  Similarity of the Proteasomal Subunit  Z  Downregulated 
by IFN-T to MECL1 Expressed Reciprocally.  Full-length cDNA 
encoding  Z  was  then  isolated  by  screening  a  human 
HepG2  cell cDNA library by hybridization with a  cDNA 
fragment synthesized by PCR. based on the amino acid se- 
quence of this fragment. The nucleotide sequence of the Z 
cDNA clone and the primary structure of the Z  protein de- 
Figure 1.  Identification of human proteasomal pair subunits Z and MECL1 reciprocally  regulated by IFN-~/. (A and B) Effect oflFN-~/on the subunit 
pattern of newly synthesized proteasomes in HeLa cells. Cells  were labeled for 3 d with [3H]leucine  in the absence or presence of IFN-~. Cell extracts 
were then treated with antiproteasomal antibodies, and the resulting immunoprecipitates were examined by 2D-PAGE and fluorography (21). The spots 
ofMHC-encoded proteasome subunits LMP2 and LMP7 and the two spots of  X and Y were up- and downregulated, respectively,  by IFN-~/treatment. 
In addition to these four spots, the intensities of two other spots were changed reciprocally  by IFN-'y treatment. Other proteasomal subunits were identi- 
fied by protein sequencing and immunoblot analysis  as described (37) and are numbered as follows: 1, XAPC7; 2, C5; 3, C9; 4, C3; 5, C7; 6, C2; 7, Iota; 
8, C10; 9, N3; 10, C8, and 11, Zeta. Proteasomes were immunoprecipitated with antiproteasomal  antibodies from unlabeled HeLa cells with or without 
IFN-~/treatment, separated by 2D-PAGE, and stained with Coomassie brilliant blue (C and/9). The newly identified spots that increased and decreased 
on IFN-~/treatment are circled. On protein sequencing by automated Edman degradation, the spot upregulated by IFN-~/was identified as MECL1, and 
the spot downregulated by IFN-~ was a newly identified subunit tentatively designated as Z (see text). 
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sequence of 980 nucleotides included the entire coding re- 
gion and  5'- and  3'-noncoding regions. A  putative poly- 
adenylation signal  (AATAAA), which  is  common  to  eu- 
karyotic  mRNAs,  was  located  26  nucleotides  upstream 
from  the poly(A) addition site. We  concluded that ATG, 
located at nucleotides  1  to  3,  is  the  initiation codon,  be- 
cause it is surrounded by a  sequence  that is similar to the 
consensus  sequence  for translation initiation (40),  and be- 
cause the open reading frame from this ATC  ;  the longest. 
The  amino acid sequence  shown  in Fig. 2  was  confirmed 
to be that of Z  of proteasomes by the fact that a sequence 
of the fragment determined chemically (residues shown by 
a  continuous  line  in  Fig.  2)  closely matched.  Subunit  Z 
consists of 277  amino acid residues with a  calculated mo- 
lecular weight of 29,965.  Its isoelectric point was calculated 
to be 7.61  (41). 
Proteasome  subunits  have  high  intersubunit  similarities 
but can be classified into two subfamilies with high similar- 
ities to the (x and 13 subunit, respectively, of the archaebac- 
terial proteasome (42). Computer-assisted homology analysis 
showed  that subunit  Z  belongs to the  13-type proteasome 
subfamily, which  is  related  to  expression  of the  catalytic 
functions of proteasomes (4). Moreover,  [3-type subunit Z 
was found to be remarkable similar to proteasome subunit 
MECL1  (58.3%  identity, excluding the NHz-terminal re- 
gion; see Fig. 3).  This fact and the observation that the ex- 
pressions of Z  and MECL1  were  regulated reciprocally in 
response to IFN-7 (Fig. 1, A  and B) suggest that subunit Z 
can be  replaced by MECL1  in  the proteasomal complex, 
just as X  and Y  can be replaced by LMP7  and LMP2,  re- 
spectively (28, 29). 
Chromosome Mapping.  To  determine  the  chromosomal 
location of the gene encoding Z, we examined 100 typical 
R-band plates of each clone using four independent clones. 
The signals with the four probes were localized to the same 
map  position.  In the  plate probed with  clone  Z-13,  43% 
exhibited complete twin spots on both  homologues,  46% 
gave incomplete single and/or twin spots on either or both 
homolognes, and the others (11%) gave no detectable spots. 
The  signals were  localized to  the  q34.11-q34.12  band  of 
chromosome 9. No doublet signals were observed on other 
chromosomes  (Fig.  4).  This  location  clearly differs  from 
that of MECL1  (16q22.1)  (38). 
IFN-T-inducible  Replacements of Three Pairs of Proteasomal 
Subunits with Possible Catalytic Functions.  Subunit Z  may be 
synthesized in a precursor form, a general feature of [3-type 
subunits of proteasomes.  The  NH2-terminal structure  of a 
proteasomal subunit (named or, 44TTIAGVVYKDGIVLG- 
ADT  61,  shaded  residues  in  Fig.  2)  was  found  by  Edman 
degradation (43, 44) to be identical to the internal sequence 
of the largest open  reading frame  of the  Z  gene.  Interest- 
ingly, MECL1  seems to be processed to the mature protein 
at a similar site to Z, because we determined the NH2-ter- 
minal sequence  of MECL1  to be 4~ 
GADTR-  (see  arrow  in  Fig.  3).  The  isoelectric 
points of the mature  Z  and MECL1  proteins were  calcu- 
lated to be 5.54 and 6.07, respectively, and their molecular 
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5 '  -  GCTTTCTTGGGAAG  -  14 
ATGC4C  GGCTGTGTC GGTGTATGC TCCAC  CAGTTGGAGGC  TTC  TC  TTT  TGATAAC TGC  C  GC  60 
M  A  A  V  S  V  Y  A  P  P  V  G  G  F  S  F  D  N  C  R 
AGGAAT GC  C  GT  C  TT  GAAGC  C  GATTTT GCAAAGAGGGGATACAAGC  TTC  CAAAGGTCC GG  120 
R  N  A  V  L  E  A  D  F  A  K  R  G  Y  K  L  P  K  V  R 
AAAACTGGCAC  GAC  CAT  C  GCTGGGGTGGTC  TATAAGGATGGCATAGTTCTT  GGAGCAGAT  180 
K  T  G  b I  Oi;Rei,R,B'i  ~i BR~ n~lR%~B  ol 
ACAAGAGCAACTGAAGGGATGGT  T  GTT  GCTGACAAGAACT  GTT  CAAAAATACAC TTCATA  240 
[]  R  A  T  E  G  M  V  V  A  D  K  N  C  S  K  I  H  F  I 
T  C  TCC  TAATATTTATTGT  TGTGGTGC TGGGACAGC TGCAGACACAGACATGACAKCC  CAG  300 
S  P  N  I  Y  C  C  G  A  G  T  A  A  D  T  D  M  T  T  Q 
C  T  CAT  T  TCT  TCCAAC  C  TGGAGCTCCACTCCC  TCTC  C  ACTGC-CCGTCTTCCCAGAGTTGTG  360 
L  I  S  S  N  L  E  L  H  S  L  S  T  G  R  L  P  R  V  V 
ACAGC  CAAT  C  GGAT  GCT  GAKGCAGAT GC  TTT  TCAGGTAT CAAGGT  TACATTGGTGCAGCC  420 
T  A  N  R  M  L  K  Q  M  L  F  R  Y  Q  G  Y  I  G  A  A 
CTAGTTT TAGGGGGAGTAGAT  GTTACTGGAC C  TCAC  CTC  TACAGCATCTATC  C  TCATGGA  480 
L  V  L  G  G  V  D  V  T  G  P  H  L  Y  S  I  Y  P  H  G 
TCAAC  TGATAAGTT GCCT  TATGTCAC CATGGGTT C  TGGC  TCC  T  TGGCAGCAATGGC  T  GTA  540 
S  T  D  K  L  P  Y  V  T  M  G  S  G  S  L  A  A  M  A  V 
TTT  GAAGATAAGTTTAGGC  CAGACATGGAGGAGGAGGAAGC  CAAGAATC TGGTGAGCGAA  600 
F  E  D  K  F  R  P  D  M  E  E  E  E  A  K  N  L  V  S  E 
GC  CAT  C  OCAGC  TGGCATC TTCAAC  GACC  TGGGC  TCC  GGAAGCAACATTGAC  C  TCT  GC  GTC  660 
A  I  A  A  G  I  F  N  D  L  G  S  G  S  N  I  D  L  C  V 
ATCAGCAAGAACAAGC  TGGATTTT C  TCC  GC  CCATACACAGT  GCC  CAACAAGAAGGGGAC  C  720 
I  S  K  N  K  L  D  F  L  R  P  Y  T  V  P  N  K  K  G  T 
AGGCTT GGCC  GGTACAGGTGTGAGJ&AAGGGAC  TAC  TGCAGTCC T  CACT  GAGAAAATCAC T  780 
R  L  G  R  Y  R  C  E  K  G  T  T  A  V  L  T  E  K  I 
CCT  C  TGGAGATT GAGGTGC T  GGAAGAAACAGT  C  CAAACAAT GGACAC  TT  C  CTGAATGC4CA  840 
P  L  E  I  E  V  L  E  E  T  V  Q  T  M  D  T  S  * 
T  CAGTGGGTGGC TGGCCGC GGT  TCTGGAAGGTGGTGAGCAT  T  GAGGC  CCAGTAAGACAC  T  900 
CATGTGGC TAGTGT TTGCC  GAAT  GAAAC  TCAAC  TCAATAAAAAACAAAAACCAAATTGGG  960 
CAGCTG- 3 '  966 
Figure  2.  Structure of cDNA for subunit Z of human proteasomes. 
(Top) Restriction endonuclease map of cloned cDNA for Z and sequenc- 
ing strategy. The solid and open boxes show the coding region and 5'- 
and 3'-noncoding regions, respectively. Continuous lines indicate the se- 
quence of the vector, Bluescript I KS  +. The numbers below the boxes 
indicate the nucleotide numbers of the first nucleotide of the initiation 
codon, ATG, and the nucleotide before the termination codon, TGA. 
Sequenced regions are shown by horizontal arrows. The bar represents 
100 bp. (Bottom) Nucleotide sequence of the cDNA encoding component 
Z and the amino acid sequence deduced from its open reading flame. 
Nucleotides are numbered in the 5' to 3' direction, beginning with the 
first residue of the putative initiation methionine codon IATG  3. The nu- 
cleotides on the 5' side are indicated by negative numbers. The predicted 
amino  acid sequence of Z  is shown  below  the  nucleotide sequence. 
Amino acid residues are numbered from the NH  2 terminus. The amino 
acid sequence corresponding to that obtained by Edman degradation of a 
fragment cleaved with lysylendopeptidase  is underlined. The sequence of 
the NH2-terufinal region, shown by shaded boxes, has been sequenced 
randomly by Edman degradation (43, 44). The termination codon TAA is 
marked with an asterisk. The possible potyadenytation signal (AATAAA) 
is double underlined. These sequence data are available from  EMBL/ 
Gen.Bank/DDBJ under accession  number D38048. Z 
MECLI 
Z 
MECLI 
Z 
MECLI 
Z 
MECLI 
Z 
MECLI 
117121  ~~~~~~~~~~i  ':  !:ii:::,  I  .......  ::~Y  "!  .........  S  .... 
Figure  3.  Sequence align- 
ment  of Z  with  MECL1 from 
human proteasomes. The cDNA 
clone  encoding subunit  Z  was 
isolated by  screening a  human 
cDNA  library (28). The  pre- 
dicted  amino acid sequences 
were  deduced from  the  nucle- 
otide sequences. The arrow indi- 
cates  a  putative processing site 
(see  text).  Identical  and  con- 
served amino acid residues are 
boxed  in  black or  shaded, re- 
spectively. Residue numbers are 
indicated. Conserved amino ac- 
ids are defined as A. S, T, P, and 
G; N, D, E, and Q; P,, K, and 
H; I, V, L, and M; F, Y, and W. 
The reported sequence of  human 
MECL1 (38) is shown. 
weights  25,295  and  24,648,  which  are  roughly consistent 
with the positions of Z  and MECL1 on 2D-PAGE (Fig. 1). 
Recently  the  NH2-terminal  threonine  residue  of the 
Thermoplasma acidophilum proteasome  [3  subunit  processed 
from the  precursor was found to be  essential  for the  pro- 
teolytic function, indicating that the proteasome is a threo- 
nine  protease  with  a  different  catalytic  mechanism  from 
those of other proteases known so far (45). This assumption 
is  consistent with  a  recent  observation that the novel pro- 
teasome-specific  microbial  inhibitor  lactacystin  modifies 
the NH2-terminal threonine residue  of subunit X  and pos- 
sibly Z  specifically and covalently, resulting in almost com- 
plete inhibition  of proteolytic activity (46).  Several eubac- 
Figure 4.  Partial R-banded metaphase plates after in situ hybridization 
with a fluorescent Z DNA probe. Arrows indicate the signals on 9q34.1 I- 
q34.12 for chromosomal  localization of  the human proteasomal Z gene. 
1811  Hisamatsu et al. 
terial  putative  {3 subunits,  Escherichia coli HslV and Rhodococcus 
[31  and [32 gene products (47), have the same NH2-termi- 
hal structure (for review see reference 48). It is therefore of 
particular interest  that the  NH 2 termini  of Z  and MECL1 
are two sequential  threonine residues  (TT- -)  and that the 
IFN-~/-induced  subunits  X  and  Y  and  the  counterparts 
they replace, LMP7 and LMP2, respectively, also have two 
NH2-terminal  threonine  residues  (28).  In  contrast,  the 
other four human [3-type subunits, HC5, HC7, HC10, and 
HN3,  do not,  suggesting that the latter  four subunits  may 
be inactive (45).  So, all the active subunits with two NH2- 
terminal threonine residues seem to be regulated by IFN-7, 
which perhaps  accounts for the  changes in the proteolytic 
functions of the proteasome. 
So far, all  14 (7c~ and 7[3) proteasomal genes of Saccharo- 
myces  cerevisiae have  been  isolated  (49).  One  of  them, 
named PUP1, which is an essential gene (50), was found to 
show high similarities  with  Z  and MECLI.  The similarity 
of Z  to PUP1  is ~54.8%,  which is higher than the 46.5% 
similarity of MECL1 to PUP1.  This suggests that the actual 
homologue of PUP1  may be  Z,  rather than  MECL1,  and 
that the  MECL1  gene may have been generated from the 
Z  gene by gene duplication.  Fig. 5 shows results of statisti- 
cal  analyses  of the  similarities  of human  proteasomal  sub- 
units.  The presence of 10 ~  subunits is curious considering 
that one 13-type ring is composed of seven subunits.  How- 
ever, from the present  and previous studies  (28,  29),  three 
[3-type  subunits,  X,  Y,  and  Z,  appear  to  be  replaced  by 
very  homologous,  but  different,  gene  products,  LMP7, 
LMP2,  and MECL1,  respectively,  in response to extracel- 
lular signals, such as IFN-  7. 
Effect of lFN-  y on the Expressions of Three Pairs of Homolo- 
gous Subunits of Proteasomes.  We compared the expressions 
of Z  and MECL1 with those of other genes ofproteasomal 
subunits responding to IFN-  7.  IFN-7 greatly increased the 
level of the mRNA  encoding MECL1  in renal  carcinoma 
KPK-1  and ACHN  cells  (Fig. 6)  and in other human cells 
such as colon carcinoma SW620  and monocytic leukemia 
Jlll  cells  (data not shown).  Similar increases  of the mP,  NAs HCa  HC3  HC8  HC9  XAPC7  ~R05-27  Zeta 
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Figure 5.  Similarities  of primary structures of various human  proteasome subunits.  Percentages of overall amino acid sequence identity between pro- 
teasomal subunits  were obtained  by computer analysis  (black box). The right side (open box) shows the percent identity confined  to highly conserved amino 
acid regions--HC2  (32-215), HC3 (32-2t3), HC8 (34-217), HC9 (31-216), XAPC7 (29-211), PR.OS-27 (36-220), Zeta (34-220), HC5 (37-218), 
HC7-I (6-181), HC10-II (8-192), HN3 (53-237), MECL1 (39-217), X (4-183), LMP7-E2 (72-251), Y (34-213), LMP2 (20-198), and Z (43-22l)--in 
which numbers show amino acid residues (start end) in the calculation.  For the sources of sequence data, see Akiyama  et al. (28). The gaps inserted to 
achieve maximal  sequence homology of amino acids were deleted in statistical  analyses. 
of LMP2 and LMP7 have been observed in various other 
types  of cells  (21,  28).  The  increases  in the  mRNAs for 
LMP2, LMP7, and MECL1  were observed after treatment 
with IFN-7 for about 12 h,  suggesting acute responses to 
IFN-7 of these three proteasomal subunits (Fig. 6 A). 
Next, we examined whether other IFNs affected the ex- 
pressions of these proteasomal genes. As shown in Fig. 6 B, 
IFN-a had no significant influence on the levels of expres- 
sion of the  genes  examined, but  IFN-I3 significantly en- 
hanced the  effect  of IFN-7  on the  expressions of LMP2 
and LMP7 without affecting MECL1 expression in ACHN 
and KPK-1 cells.  This finding suggests that the mechanism 
regulating expression of subunit MECL1  may differ some- 
what from those regulating subunits LMP2 and LMP7, al- 
though IFN-'y acts as a major inducer of all of them, and 
that the physiological role ofproteasomes containing MECL1 
may differ from that ofproteasomes containing LMP2 and/ 
or LMP7. On the other hand, the amounts of the mR.NAs 
of multiple oL- and I]-type subunits, including Z,  X,  and  Y, 
were not affected appreciably by treatment with IFN-7 or 
other IFNs (Fig. 6). 
We  examined the  effect  of IFN-  7  on the  amounts of 
Figure  6.  Effect of IFN-7  on  expression of 
various proteasome subunit genes in various hu- 
man cells. (A)  KPK-1 cells were treated with 
IFN-~/ (500 U/ml) for the indicated times, and 
then amounts of mKNAs encoding proteasomal 
proteins of Z, MECL1, X, LMP7, Y, and LMP2 
were analyzed by RNA blot hybridization (21). 
(B) Effects of various IPNs on the expressions of 
snbunits in renal carcinoma ACHN and KPK-I 
cells. IFN-a (500 U/ml) and IFN-13 (500 U/ml) 
were added individually  or in combination with 
IFN-y (500 U/ml) for 3 d. Figure  7.  lmmunoblot analyses 
ofproteasomes  with various antipro- 
teasome antibodies in  KPK-1 cells 
cultured with IFN-y. Cells were 
treated with IFN-y as in Fig. 6 A. 
these proteasomal subunits. As shown in Fig.  7, immuno- 
blot analysis showed marked increases of the LMP2, LMP7, 
and MECL1 proteins in KPK-1 cells,r  roughly corre- 
lated with the amounts of their mRNAs (Fig. 6). However, 
neither the protein levels of X, Y, and Z  nor the amounts 
of their mR.NAs were greatly affected by IFN-y  (Fig.  1). 
This suggests  that the complete loss or marked decrease in 
the expressions ofsubunits X, Y, and Z  induced by IFN-~/ 
is due to posttranslational degradation of X, Y,  and  Z,  as 
proposed before (29,  30). However, the amounts of these 
three proteins were found to decrease gradually 2-3 d after 
stimulation  by IFN-~/.  Moreover,  we  showed  previously 
that IFN-~/has no effect on the subunit pattern of preexist- 
ing proteasomes (21).  Probably, although the induction of 
proteasomes  containing  LMP7,  LMP2,  and  MECL1  by 
IFN-'/is rapid,  the overall change from preexisting X/Y/Z- 
type proteasomes is slow, because of the large pool size and 
slow turnover of  the latter, constitutive proteasomes (8, 51). 
Discussion 
Proteasomes  containing  LMP2  and  LMP7  have  been 
thought to be  responsible for the MHC  class I-restricted 
antigen-processing pathway, because transfection of LMP2 
and  LMP7  cDNAs  altered  the  proteolytic specificity  of 
proteasomes (52).  Recently, we found that IFN-~ induced 
not  only  high  syntheses  of LMP2  and  LMP7,  but  also 
marked reductions in the accumulation of two unidentified 
proteasome subunits, tentatively named X  and Y  (21,  27). 
This suggests  the induction by IFN-~/ of the replacements 
of proteasome subunits X  and Y  by their highly homolo- 
gous  subunits  LMP7  and  LMP2,  respectively  (28-30), 
which  is  presumably responsible  for change  of the  func- 
tional  diversity  of proteasomes.  In  fact,  cells  from  mice 
with a homologous deletion of the LMP7 show deficien- 
cies in class I-restricted antigen presentation, which is due 
to reduced intracelluar antigen processing (23).  Disruption 
of the  LMP2  also  resulted in  defective cellular immunity 
under certain  conditions,  such  as viral infections in  gene 
knockout mice, although in intact animals,  dysfunction of 
LMP2  did  not  have  any  appreciable  effects  (24).  Appar- 
ently, LMP2 is necessary for the presentation of some anti- 
gens to cytotoxic T  lymphocytes (53).  On the other hand, 
the defect of antigen presentation in T2 cells, which have 
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deletions  of not  only  the  TAP1/2  genes  but  also  the 
LMP2/LMP7  genes, can be suppressed almost completely 
by transfections  of TAP1/2  genes  into  the  mutant  cells, 
suggesting that LMP2/LMP7 did not have much effect on 
the  antigen-processing pathway  (31-33).  The latter find- 
ings  suggest  that  there  may be  an  additional  proteasome 
gene(s)  responsible for antigen processing mediated by the 
proteasome. Here we demonstrated the existence of a third 
pair of proteasome subunits reciprocally regulated by IFN-~/ 
and propose that IFN-~/ induces not only replacements of 
X  and Y  by LMP7 and LMP2, but also substitution of Z 
for MECL1, producing proteasomes responsible for antigen 
processing. Actually, IFN-~/alters the proteolytic specificity 
of proteasomes,  increasing  their  activities for cleavage  of 
peptide bonds on the carboxyl side of basic  and hydropho- 
bic  amino  acid residues  of fluorogenic substrates,  but de- 
creasing their activities for peptides containing acidic amino 
acid  residues  (19-21).  These  changes  of the  proteasomal 
functions would be more appropriate for the generation of 
MHC class I-restricted peptides, because the carboxyl sides 
of antigenic peptides associated with the cell surface class I 
molecules consist mainly of hydrophobic and basic  amino 
acid residues, not acidic amino acid residues (54).  In con- 
trast,  reduction of chymotryptic activity by IFN-~  is  re- 
ported by other investigators  (25,  39),  but the  reason for 
these  controversial results is unclear at present.  It also  re- 
mains unknown whether the new pair of substituted sub- 
units,  Z  and MECL1,  affects  the proteolytic functions  of 
proteasomes. This point is currently being examined. 
The  subunit  organization  of eukaryotic proteasomes is 
presumed to  be  0m(1-7)J3n(1-7)[3n(1-7)om(1-7), where  n 
indicates the number of seven heterogeneous subunits  (2). 
7  human  cDNAs  encoding  or-type  subunits  have  been 
cloned, whereas 10 human cDNAs of 13 subunits, including 
Z,  have been found so far (see  Fig.  5).  In  this  study, we 
suggest that IFN-~/may induce subunit replacements of X, 
Y, and Z by LMP7, LMP2, and MECL1, respectively, pro- 
ducing proteasomes that are perhaps more appropriate for 
the immunological processing of endogenous antigens, and 
so we propose the term immunoproteasomes for function- 
ally  distinct proteasomes induced by IFN-',/.  Thus,  in re- 
sponse to extracellular signals, such as IFN-~/, some [3-type 
subunits  appear to  be  replaced by very homologous, but 
different,  gene  products,  which  might  be  generated  by 
gene  duplication.  Therefore, the  total number of [3-type 
subunits may have increased in multicellular organisms dur- 
ing  evolution for acquisition  of the  MHC-restricted im- 
mune system. Previously, we proposed the name molecular 
adaptation for the interesting new phenomenon in which 
the proteasomal multisubunit complex acquires functional 
diversity by change in molecular composition in response 
to environmental stimuli (30). The subunit changes of pro- 
teasomes in  various  physiological conditions may be  one 
reason why the proteasome has  such a complex organiza- 
tion, but further analyses  are  required to  determine their 
structural-functional relationships. 
Proteasomes are present in both the nucleus and the cy- 
toplasm  of a variety of eukaryotic cells,  and  are localized predominantly  in  the  nuclei  of various  types  of rapidly 
growing cells.  We found that most of the cx-type subunits 
contain  nuclear location signal  (NLS)  and complementary 
NLS moti~ (55). Thus different organizations of the 0~-type 
subunits may alter the intracellular localization of the pro- 
teasome. On the other hand, yeast genetical studies indicate 
that the [3 subunits are related with the active function, but 
the  catalytic mechanism remains unsolved  (49).  Recently, 
it was demonstrated by x-ray crystallography (56) and site- 
directed  mutagenesis  (45)  that  the  T.  acidophilum  protea- 
some is a novel threonine protease, the NH2-terminal thre- 
onine residue of the [3 subunit,  essential for the proteolytic 
function.  Interestingly, three pairs of 10 homologous, but 
distinct,  [3-type subunits of eukaryotic proteasomes, that is, 
X/LMP7,  Y/LMP2,  and Z/MECL1  subunits hut not the 
remaining  four  [3  subunits,  have  acquired  a  conserved 
NH2-terminal threonine residue processed from their pre- 
cursors, suggesting that they are active subunits.  In consid- 
ering these new facts,  our previous finding for the cDNA 
cloning of X  and Y  (28)  and  the present  observation re- 
garding cDNA cloning  of Z  are  very important,  because 
they  provide  entirely  new  information  suggesting  that 
IFN-y induces replacements of three pairs of homologous 
subunits  with  possibly catalytic  functions,  which  may be 
responsible  for  the  IFN-~-dependent  alteration  of pro- 
teolytic  specificity of the  proteasome reported  previously 
(19-21). 
IFN-y plays a central role in immunomodulatory func- 
tions through upregulation of the expressions of a variety of 
genes  responsible  for  the  immune  response.  As  reported 
previously (21),  IFN-y had no effect on the cellular con- 
tent ofproteasomes. Therefore, it must modify the subunit 
organization and functions of proteasomes, resulting in ac- 
celerated or modulated processing of endogenous antigens. 
This is a novel mechanism for the immunomodulato/3, ac- 
tion of IFN-y, clearly differing from the previously known 
mechanism involving marked increases in the cellular con- 
centrations  of TAP  and  MHC  molecules  responsible  ibr 
antigen  presentation  by  cells,  which  is  stimulated  at  the 
transcriptional level of these genes. Ma et al. (57) and Dubiel 
et al. (58) found an activator protein of the 20S proteasome, 
named  PA28  (or  lls  regulator).  It  is  a  homooligomeric 
complex that binds directly to both ends of the cylindrical 
20S  molecule  (4,  59).  Intriguingly,  PA28  consists  of two 
homologous  proteins,  named  PA28cx  (equivalent  to  the 
originally described PA28/11S  regulator) and PA2813 (60), 
and the genes encoding these two activators have also  re- 
cently been found to be responsive to  IFN-y (60,  61).  In 
fact,  PA28ci  is  identical  to  a  protein  clones  previously, 
named  IGUP  1-5111,  which  is  one  of the  major  gene 
products  induced  by  IFN-y  in  primary  human  kerati- 
nocytes (62).  The purified PA28 protein greatly stimulates 
multiple peptidase activities of the 20S proteasome without 
affecting  destruction  of large  protein  substrates  (57,  58), 
suggesting that it may cooperate with the 26S proteasome 
in  a  sequential  proteolytic  pathway.  Thus,  these  newly 
identified IFN-y-regulated activator genes in combination 
with three pairs oflFN-y-regulated proteasome genes may 
provide answers to unsolved fundamental questions  of re- 
dundancy  in  the  antigen-processing  pathway.  As  men- 
tioned  in  the  Introduction,  the  26S  proteasome is  a large 
complex  consisting  of two  functionally  distinct  units,  a 
central  cylindrical 20S  proteasome with  at least three  dis- 
tinct endopeptidase activities and regulatory parts attached 
to both ends of this central part that have ATPase and de- 
ubiquitinating actions (2, 4, 6, 9,  I0). At present it remains 
unclear whether IFN-y alters composition of the regulator 
complex. 
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